New Revenue Sources in the Isoflavones Market

The report Isoflavones Market by Source (Soy, Red Clover), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), Form (Powder and Liquid), and Region (North America, Europe, Asia Pacific, RoW) – Global Forecast to 2025″ The isoflavones market is estimated at USD 1.1 billion in 2019 and is projected to grow at a CAGR of 4.7% from 2019 to 2025 to reach USD 1.5 billion by 2025. The market is driven by the increasing incidences of chronic diseases, the rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population.

Market Driver: Prevalence of menopausal issues

Women in their menopause stage experience various issues such as hot flashes, insomnia, and, in numerous cases, sexual dysfunction. Many women prefer supplements containing estrogen, which may significantly increase the risk of blood clots, stroke, or breast or uterine cancer. Thus, estrogen may not be an option for many women, depending on their health and family health history. Women are currently inclining toward supplements with naturally therapeutic ingredients to manage their menopause symptoms with fewer risks. In response to such changing preferences of women, supplement manufacturers have turned to natural alternatives. They have started utilizing soy isoflavones instead of estrogen, as it mimics the estrogen characteristics and provides estrogen effects that aid in reducing menopausal symptoms such as hot flashes and fatigue.

Owing to the rising issues related to menopause and women’s inclination toward supplements with natural alternatives, the demand for isoflavones from the nutraceutical industry is projected to grow in the coming years.

Schedule a call with our Analysts to discuss your business needs:

Market Opportunity: Emerging Technologies

Some of the recent advancements in drug development include the use of nanotechnology for the synthesis of APIs. The emergence of nanoparticle technologies for efficient delivery of APIs shows promising potential as a novel and efficient approach.

Nanobodies are similar to single-domain antibodies that can bind to specific antigens; however, they are much smaller in size than antibodies. Nanobodies are rapidly becoming an attractive technology platform for pharmaceutical development. Chitosan and Eudragit nanoparticles of Genistein, the predominant isoflavone found in soy products for cancer therapy, have been significantly evaluated for the treatment of chronic diseases in the past few years. The delivery of Genistein-loaded Chitosan and Eudragit S100 loaded polymeric nanoparticles has proven to be a feasible approach to treat cancer.

Similarly, bispecific antibodies, which can bind to two different epitopes either on the same or different target, are attracting the attention of market players. Such emerging technologies have the potential to create attractive opportunities for market players.

The North American region is projected to account for the largest market share during the forecast period.

The North American market for isoflavones is the largest due to the increasing awareness of healthy food ingredients and the trend of weight management among consumers. Increasing cases of obesity in North America increase the focus on weight management techniques & attracting consumers toward healthy and natural food products with natural ingredients, thereby propelling the demand for isoflavones in the region.

The powder segment is projected to record the fastest growth during the forecast period.

The powder segment is projected to grow at a higher CAGR during the forecast period owing to factors such as ease in handling and usage in a wide range of pharmaceutical and nutraceutical applications. A majority of global players such as ADM, Frutarom, and Herbo Nutra offer powdered isoflavones. Dietary supplements, clear drinks, food, beverages, and nutraceutical supplements are some of the popular applications where isoflavones are used mostly in powder form. 

To know more get a PDF Copy:

The red clover segment is projected to be the fastest-growing in the isoflavones market during the forecast period.

Red clover, with the scientific name Trifolium pretense, is a wild leguminous, perennial herb that has nutritional benefits and properties. Full applications of red clover in pharmaceuticals, food & beverage and nutraceuticals industry are driving its demand in the global market.

Top Players Analyzed:

ADM (US), BASF (Germany), DSM (Netherlands), International Flavors and Fragrances (Frutarom) (US), Shanghai Freemen (US), and Nexira Inc. (France).